These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 25742210)

  • 1. Reducing the cost and burden of depression: incorporate heart and get an early start.
    Goldstein BI
    J Clin Psychiatry; 2015 Feb; 76(2):e216-7. PubMed ID: 25742210
    [No Abstract]   [Full Text] [Related]  

  • 2. The economic burden of adults with major depressive disorder in the United States (2005 and 2010).
    Greenberg PE; Fournier AA; Sisitsky T; Pike CT; Kessler RC
    J Clin Psychiatry; 2015 Feb; 76(2):155-62. PubMed ID: 25742202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the burden of depression.
    Culpepper L
    J Clin Psychiatry; 2011 Jun; 72(6):e19. PubMed ID: 21733472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The societal cost of depression: evidence from 10,000 Swedish patients in psychiatric care.
    Ekman M; Granström O; Omérov S; Jacob J; Landén M
    J Affect Disord; 2013 Sep; 150(3):790-7. PubMed ID: 23611536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The medical treatment of depression, 1991-1996: productive inefficiency, expected outcome variations, and price indexes.
    Berndt ER; Bir A; Busch SH; Frank RG; Normand SL
    J Health Econ; 2002 May; 21(3):373-96. PubMed ID: 12022264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of depression among adults in Japan in 2005.
    Sado M; Yamauchi K; Kawakami N; Ono Y; Furukawa TA; Tsuchiya M; Tajima M; Kashima H; ; Nakane Y; Nakamura Y; Fukao A; Horiguchi I; Tachimori H; Iwata N; Uda H; Nakane H; Watanabe M; Oorui M; Funayama K; Naganuma Y; Hata Y; Kobayashi M; Ahiko T; Yamamoto Y; Takeshima T; Kikkawa T
    Psychiatry Clin Neurosci; 2011 Aug; 65(5):442-50. PubMed ID: 21851453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
    Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
    J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder.
    Snedecor SJ; Botteman MF; Schaefer K; Sarocco P; Barry N; Pickard AS
    J Ment Health Policy Econ; 2010 Mar; 13(1):27-35. PubMed ID: 20571180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COSTS OF DEPRESSION FROM CLAIMS DATA FOR MEDICARE RECIPIENTS IN A POPULATION-BASED SAMPLE.
    Alexandre PK; Hwang S; Roth KB; Gallo JJ; Eaton WW
    J Health Hum Serv Adm; 2016; 39(1):72-94. PubMed ID: 27483975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of short-term psychodynamic psychotherapy and solution-focused therapy in the treatment of depressive and anxiety disorders during a one-year follow-up.
    Maljanen T; Paltta P; Harkanen T; Virtala E; Lindfors O; Laaksonen MA; Knekt P;
    J Ment Health Policy Econ; 2012 Mar; 15(1):13-23. PubMed ID: 22611089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical guidelines for the treatment of depressive disorders, I. Definitions, prevalence, and health burden.
    Parikh SV; Lam RW;
    Can J Psychiatry; 2001 Jun; 46 Suppl 1():13S-20S. PubMed ID: 11441768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender patterns in cost effectiveness of quality improvement for depression: results of a randomized, controlled trial.
    Schoenbaum M; Sherbourne C; Wells K
    J Affect Disord; 2005 Aug; 87(2-3):319-25. PubMed ID: 16005520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model of the economic impact of a bipolar disorder screening program in primary care.
    Menzin J; Sussman M; Tafesse E; Duczakowski C; Neumann P; Friedman M
    J Clin Psychiatry; 2009 Sep; 70(9):1230-6. PubMed ID: 19689919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness measures of major depressive disorder in pharmacoeconomic evaluations.
    Casciano R
    Manag Care Interface; 2003; Suppl B():14-5. PubMed ID: 12647608
    [No Abstract]   [Full Text] [Related]  

  • 15. The societal costs of chronic major depression.
    Pincus HA; Pettit AR
    J Clin Psychiatry; 2001; 62 Suppl 6():5-9. PubMed ID: 11310818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The health value and cost of care for major depression.
    Watkins KE; Burnam MA; Orlando M; Escarce JJ; Huskamp HA; Goldman HH
    Value Health; 2009; 12(1):65-72. PubMed ID: 19911440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative cost analysis of generalized anxiety disorder and major depressive disorder patients in secondary care from a national hospital registry in Finland.
    Kujanpää T; Ylisaukko-Oja T; Jokelainen J; Linna M; Timonen M
    Nord J Psychiatry; 2014 Jul; 68(5):306-10. PubMed ID: 23931684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
    Simpson KN; Welch MJ; Kozel FA; Demitrack MA; Nahas Z
    Adv Ther; 2009 Mar; 26(3):346-68. PubMed ID: 19330495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.
    Asche CV; Joish VN; Camacho F; Drake CL
    Curr Med Res Opin; 2010 Aug; 26(8):1843-53. PubMed ID: 20515321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance.
    Birnbaum HG; Kessler RC; Kelley D; Ben-Hamadi R; Joish VN; Greenberg PE
    Depress Anxiety; 2010; 27(1):78-89. PubMed ID: 19569060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.